<DOC>
	<DOCNO>NCT01957670</DOCNO>
	<brief_summary>The study ass safety , tolerability feasibility Lacrima investigational medical device treat dry eye patient</brief_summary>
	<brief_title>Pilot Study Clinical Evaluate Device Prototypes Dry Eye Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Main 1 . Male female , 18 year age screen 2 . Diagnosis mild moderate Dry Eye , define : 1 . Positive corneal fluorescein staining , define corneal punctate fluorescein stain score ≥3 either eye National Eye Institute evaluation scale sum 5 area , 03 score scale ; AND 2 . Schirmer Test score ( anesthesia , 5 minute &lt; 5 mm either eye ) ; AND 3 . OSDI score ≥12 OSDI score &lt; 33 Main 1 . Persistent intraocular inflammation infection include conjunctivitis time study 2 week prior study start . 2 . Any concomitant active history eye disease include , limited lid abnormality , nasolacrimal obstruction , active ulcer , glaucoma ocular herpes simplex virus infection 3 . Patients currently use topical steroidal antiinflammatory eye drop 1 month prior screen 4 . Receipt type topical artificial eye drop within 3 day prior screen 5 . Receipt topical cyclosporine eye drop within 3 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Keratoconjunctivitis Sicca</keyword>
	<keyword>Dry Eye Syndromes</keyword>
</DOC>